Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Definition and Prognosis of Atrioventricular Regurgitation in Transthyretin Amyloid Cardiomyopathy - a Prospective International Multicenter Study

NCT06836011 is registered in ClinicalTrials.gov with Medical University of Vienna as lead sponsor.

NCT NCT06836011
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06836011 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Definition and Prognosis of Atrioventricular Regurgitation in Transthyretin Amyloid Cardiomyopathy - a Prospective International Multicenter Study
Lead sponsor
Medical University of Vienna
Phase
Observational
Overall status
Recruiting
Start date
January 1, 2025
Completion date
December 31, 2026
Enrollment
600 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

attr amyloidosis wild type, attr amyloidosis with cardiomyopathy, attr-cm, mitral regurgitation, tricuspid regurgitation